Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 4/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | HTR2C | P28335 | 4/20 | 0.37 |
| ▸ | QDPR | P09417 | 2/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | KHK | P50053 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4789631 | 0.68 | HTR2C (0.56) | HTR6HTR2ASIGMAR1HTR2CQDPR | |
| Hydrochloric Acid SCHEMBL9958496 | 0.67 | HTR2C (0.57) | HTR6HTR2ASIGMAR1HTR2CQDPR | |
| SCHEMBL29029335 | 0.67 | CCNT1 (0.41) | SIGMAR1HTR2CQDPR | |
| Hydrochloric Acid SCHEMBL29266476 | 0.66 | CCNT1 (0.40) | SIGMAR1HTR2CQDPR | |
| SCHEMBL1671185 | 0.65 | — | — | |
| SCHEMBL15077316 | 0.65 | HTR6 (0.51) | HTR6HTR2ASIGMAR1HTR2CQDPR | |
| Hydrochloric Acid SCHEMBL1513499 | 0.65 | HTR2C (0.53) | HTR6HTR2ASIGMAR1HTR2CQDPR | |
| SCHEMBL4790049 | 0.65 | HTR2C (0.53) | HTR6HTR2ASIGMAR1HTR2CQDPR | |
| SCHEMBL15770800 | 0.64 | HTR2C (0.41) | HTR6HTR2ASIGMAR1HTR2CHRH3 | |
| SCHEMBL4789895 | 0.63 | HTR2C (0.57) | HTR6HTR2ASIGMAR1HTR2CQDPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116940563-A | CDK inhibitors and their use as pharmaceuticals | 普莱鲁德疗法有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116583283-A | CDK inhibitors and their use as pharmaceuticals | 普莱鲁德疗法有限公司 | 2023-08-11 | — | — | CN | disclosed |